[Federal Register Volume 65, Number 121 (Thursday, June 22, 2000)]
[Notices]
[Pages 38859-38860]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-15688]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 8, 1999, and published in the Federal 
Register on October 18, 1999, (64 FR 56226), Chirex Technology Center, 
Inc., DBA Chirex Cauldron, 383 Phoenixville Pike, Malvern, Pennsylvania 
19355, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
amphetamine (1100), a basic class of controlled substance listed in 
Schedule II.
    The firm plans to bulk manufacture amphetamine and its salts for 
product development.

[[Page 38860]]

    DEA has considered the factors in title 21, United States Code, 
section 823(a) and determined that the registration of Chirex 
Technology Center, Inc., DBA Chirex Cauldron to manufacture amphetamine 
is consistent with the public interest at this time. DEA has 
investigated the firm to ensure that the company's registration is 
consistent with the public interest. The investigation included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic class of controlled substance listed above is 
granted.

    Dated: June 7, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-15688 Filed 6-21-00; 8:45 am]
BILLING CODE 4410-09-M